BDX vs INFU
BDX: BD is a leading global medical technology company providing essential medical devices, diagnostic systems, and laboratory solutions to healthcare providers and researchers worldwide. INFU: InfuSystem is a specialized provider of durable medical equipment and managed healthcare services that enables the seamless transition of oncology and other infusion therapies from clinical settings to the home.
Side-by-side fundamentals
| Metric | BDX | INFU | Edge |
|---|---|---|---|
| Price as of 2026-07-23 close | $152.97 | $8.89 | |
| Market cap as of 2026-07-24 | $42.2B | $180M | |
| P/E as of 2026-07-24 | 37.07 | 22.70 | INFU lower |
| PEG as of 2026-07-24 | -20.92 | 0.16 | BDX lower |
| Net margin as of 2026-07-24 | +5.3% | +5.6% | INFU higher |
| Gross margin as of 2026-07-24 | +47.0% | +56.8% | INFU higher |
| Operating margin as of 2026-07-24 | +10.2% | +9.1% | BDX higher |
| ROE as of 2026-07-24 | +4.5% | +14.0% | INFU higher |
| ROA as of 2026-07-24 | +2.1% | +7.9% | INFU higher |
| Debt / equity as of 2026-07-24 | 0.72 | 0.33 | INFU lower |
| Revenue growth (YoY) as of 2026-07-24 | +2.4% | +3.5% | INFU higher |
| Revenue CAGR (3y) SEC XBRL | +5.0% | +9.3% | INFU higher |
| Dividend yield as of 2026-07-24 | +2.7% | n/a | |
| Dividend streak (yrs) SEC XBRL | 5 | n/a | |
| Beta as of 2026-07-24 | 0.21 | 1.49 | |
| 1-year return as of 2026-07-23 close | +6.6% | +54.8% | INFU higher |
Fundamentals: Finnhub, as of 2026-07-24. Filings: SEC EDGAR. Prices are delayed daily-close data.
Last updated 2026-07-23.
Informational only — NOT financial advice. All figures are delayed daily-close data from SEC EDGAR & Finnhub, shown with their as-of date; "Edge" cells are a pure numeric comparison, not a recommendation.